CLEVELAND (Reuters) – Women in Ohio would be prohibited from receiving abortions because of a fetal Down syndrome diagnosis under a bill that passed the state senate on Wednesday and is heading to Republican Governor John Kasich’s desk.
Kentucky may become the first state in the US to effectively outlaw abortion. But the women in Appalachia, where teen pregnancies soar, poverty looms and everyone knows each other’s business, would simply like birth control, sex ed and honest talk. As politics work against them, they’re rising up to do what others won’t do for them.
CHICAGO/LONDON (Reuters) – When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall findings were that it protected against the world’s biggest and fastest growing mosquito-borne disease.
WASHINGTON (Reuters) – U.S. House Republicans proposed on Tuesday to delay or suspend several taxes under former President Barack Obama’s healthcare law, including a tax on medical devices and the so-called “Cadillac” tax on generous health insurance plans.
Don’t doubt it: “Man flu” is real, or so says one Canadian researcher who was “tired of being accused of overreacting.”
(Reuters) – The U.S. Food and Drug Administration on Monday proposed creating a new fast track to market for certain medical devices and a potential reduction in the amount of safety data required for approval.
LONDON (Reuters) – Scientists have for the first time fixed a protein defect that causes Huntington’s disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
Cara Pressman, 15, wept as her parents told her their insurance company denied her for a minimally invasive brain surgery that could end the seizures that have haunted her since she was 9. In the six weeks since the rejection, Cara has had dozens more seizures. Pressed by CNN, Aetna still refuses to approve the surgery — over the objections of her own doctors.
ZURICH (Reuters) – Combining Roche’s Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
LOS ANGELES (Reuters) – Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.